186 related articles for article (PubMed ID: 22807384)
1. Rapid prescreen of cervical liquid-based cytology preparations: results of a study in an academic medical center.
Frable WJ; Pedigo MA; Powers CN; Yarrell C; Ortiz B; Clark ME; Ebron T
Diagn Cytopathol; 2012 Aug; 40(8):691-7. PubMed ID: 22807384
[TBL] [Abstract][Full Text] [Related]
2. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
Djemli A; Khetani K; Auger M
Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
[TBL] [Abstract][Full Text] [Related]
3. Improvement in the routine screening of cervical smears: A study using rapid prescreening and 100% rapid review as internal quality control methods.
Tavares SB; Alves de Sousa NL; Manrique EJ; Pinheiro de Albuquerque ZB; Zeferino LC; Amaral RG
Cancer Cytopathol; 2011 Dec; 119(6):367-76. PubMed ID: 21954191
[TBL] [Abstract][Full Text] [Related]
4. Rapid prescreening is as effective at reducing screening error as postscreening with the FocalPoint automated screening device.
Wilgenbusch H; Mueller G; Neal M; Renshaw AA
Diagn Cytopathol; 2011 Nov; 39(11):818-21. PubMed ID: 20949451
[TBL] [Abstract][Full Text] [Related]
5. [Comment on diagnosis of atypical squamous cells using new the Bethesda system 2001].
Wang Y; Bian ML; Liu J
Zhonghua Fu Chan Ke Za Zhi; 2004 Jan; 39(1):27-9. PubMed ID: 14989984
[TBL] [Abstract][Full Text] [Related]
6. [The PAPNET system in the rescreening of negative cervical/vaginal smears. A study from the Imola cytology laboratory].
Ghidoni D; Fabbris E; Folicaldi S; Amadori A; Medri M; Bucchi L; Bondi A
Pathologica; 1998 Aug; 90(4):357-63. PubMed ID: 9793395
[TBL] [Abstract][Full Text] [Related]
7. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
8. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
[TBL] [Abstract][Full Text] [Related]
9. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
[TBL] [Abstract][Full Text] [Related]
10. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear.
Pitman MB; Cibas ES; Powers CN; Renshaw AA; Frable WJ
Cancer; 2002 Jun; 96(3):128-34. PubMed ID: 12115299
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
[TBL] [Abstract][Full Text] [Related]
12. Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening?
Kanber Y; Charbonneau M; Auger M
Cancer Cytopathol; 2015 Dec; 123(12):739-44. PubMed ID: 26348845
[TBL] [Abstract][Full Text] [Related]
13. Rapid prescreening as a quality assurance measure in cervical cytology.
Repse-Fokter A; Caks-Golec T
Acta Cytol; 2009; 53(3):268-70. PubMed ID: 19534265
[TBL] [Abstract][Full Text] [Related]
14. Quality assurance in cervical smears: 100% rapid rescreening vs. 10% random rescreening.
Amaral RG; Zeferino LC; Hardy E; Westin MC; Martinez EZ; Montemor EB
Acta Cytol; 2005; 49(3):244-8. PubMed ID: 15966284
[TBL] [Abstract][Full Text] [Related]
15. Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica.
Sherman ME; Schiffman M; Herrero R; Kelly D; Bratti C; Mango LJ; Alfaro M; Hutchinson ML; Mena F; Hildesheim A; Morales J; Greenberg MD; Balmaceda I; Lorincz AT
Cancer; 1998 Oct; 84(5):273-80. PubMed ID: 9801201
[TBL] [Abstract][Full Text] [Related]
16. Measuring the significance of workload on performance of cytotechnologists in gynecologic cytology: a study using rapid prescreening.
Deschenes M; Renshaw AA; Auger M
Cancer; 2008 Jun; 114(3):149-54. PubMed ID: 18412150
[TBL] [Abstract][Full Text] [Related]
17. One hundred percent thorough quality control rescreening of liquid-based monolayers in cervicovaginal cytopathology.
Rowe LR; Marshall CJ; Bentz JS
Cancer; 2002 Dec; 96(6):325-9. PubMed ID: 12478679
[TBL] [Abstract][Full Text] [Related]
18. [Applicative aspects of liquid-based cytology in cervical cancer screening].
Liverani M; De Paola F; Danesi S; Fedriga R; Dalbuoni V; Agnoletti R; Amadori AR; Mirra F; Bonoli W; Saragoni L
Pathologica; 2006 Dec; 98(6):629-34. PubMed ID: 17285839
[TBL] [Abstract][Full Text] [Related]
19. Rapid pre-screening is more sensitive in liquid-based cytology than in conventional smears.
Dudding N; Renshaw AA; Ellis K
Acta Cytol; 2011; 55(1):54-6. PubMed ID: 21135523
[TBL] [Abstract][Full Text] [Related]
20. Significance of atypical repair in liquid-based gynecologic cytology: a follow-up study with molecular analysis for human papillomavirus.
Ng WK; Li AS; Cheung LK
Cancer; 2003 Jun; 99(3):141-8. PubMed ID: 12811854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]